Mycoplasma infection after vital organ transplantation in the early postoperative period


Gorina L.G., Krupenio T.V., Gorskaya E.M., Kornilov M.N., Cirulnikova I.E., Goncha­rova S.A., Gamova N.A., Rakowskaya I.V., Gabrielian H.I.

1Honored Academician N.F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of Russia, Moscow, Russia; 2V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Ministry of Health of Russia, Moscow, Russia
Objective. To detect Mycoplasma species in solid organ transplant recipients following transplantation.
Subjects and methods. Ninety-nine transplant recipients were examined for Mycoplasma infection after heart, liver, or kidney transplantation. The patients were divided into 2 groups: 1) 86 patients having a good postoperative period; 2) 13 patients whose postoperative period was poor. Mycoplasma antigens were determined by aggregate hemagglutination assay; antibodies were detected by the passive hemagglutination assay.
Results. Markers of different Mycoplasma species were identified in patients after organ transplantation. In patients who had undergone orthotopic heart transplantation (OHT), Mycoplasma pneumoniae was identified almost twice more common than in those who had related liver fragments transplantation (RLFT): 54.5 ± 0.08 and 31.0 ± 0.09%, respectively (p < 0.05). Ureaplasma spp. also prevailed in patients who had undergone OHT versus those who had RLFT, but these data were not statistically significant (p> 0.05). Ureaplasma spp. was more frequently detected in Group 2 than in Group 1: its isolation frequency was 46.2 ± 0.14 and 36.0 ± 0.05%, respectively (p < 0.05). The isolation frequency of M. pneumoniae was 47.7 ± 0.05% in Group 1 and 30.8 ± 0.13% in Group 2 (p> 0.05).
Conclusion. It is important to detect Mycoplasma not only for the prevention and treatment of its infection in the early in-hospital period, but also for the prevention of late complications.

Literature


1. Gautier S.V., Khomyakov S.M. [Organ donation and transplantation in the Russian Federation in 2015]. Vestnik Transplantologii i Iskusstvennykh Organov 2016; 2: 6–27. (In Russ.).

2. Razin S., Herrmann R. Molecular biology and pathogenicity of mycoplasmas. New York: Kluwer, 2002; 45–733. Раковская И.В. Микоплазмы и микоплазмозы человека. Руководство для врачей. М., 1999. 35 р.

3. Rakovskaya I.V. [Mycoplasma and human mycoplasmosis. Guidelines for doctors]. Moscow, 1999. 35 р. (In Russ.).

4. Selipanova E. E., Feklisova L. V., Savitskaya N. A. Galkina L. A., Casanova S.P. [Mycoplasmosis and chlamydial infection. Textbook]. Moscow: Moskovskij oblastnoj nauchnoissledovatel’skij klinicheskij institut im. M.F. Vladimirskogo, 2009. (In Russ.).

5. [Mycoplasmosis]. In: Lobzin Yu. V., Zhdanov V.P. (eds.). [Guide for communicable diseases]. In 2 v. V. 2. Saint-Petersburg: Foliant Publ., 2011; 553–9. (In Russ.).

6. Ivanova V.V., ed. [Infectious diseases in children]. Moscow: Medicinskoe informacionnoe agentstvo, 2009; 279–84. (In Russ.).

7. Borkhsenius S.N., Chernova O.A., Chernov V.M., Vonsky M.S. [Mycoplasmas: molecular and cellular biology, interaction with the immune system of mammals, pathogenicity, diagnosis]. St.Petersburg: Nauka Publ., 2002. 316 р. (In Russ.).

8. Kurz H., Gopfrich H., Huber K., Kruqluger V.V. Spectrum of pathogens of in-patient children and youths with community acquired pneumonia: a 3 year survey of a community hospital in Vienna, Austria. Wien Klin. Wochenschr. 2013; 125(21–22): 674–9.

9. Lui G., Lee N., Rainer T.H., Man S.Y., Cockram C.S., Antonio G.E, Ng M.H., Chan M.H., Chau S.S., Mak P., Chan P.K., Ahuja A.T., Sung J.J., Hui D.S. Role of ≪atypical pathogens≫ among adult hospitalized patients with community – acquired pneumonia. Respirology 2009; 14(8): 1098–105. DOI: 10.1111/j.1440-1843.2009.01637.x.

10. Daxbock F., Brunner G., Popper H., Krause R., Schmid K., Krejs G.J., Wenisch C. A case of lung transplantation following Mycoplasma pneumonia infection. Eur. J. Clin. Microbiol. Infect. Dis. 2002; 21(4): 318–40.

11. Zaplatnikov A. L., Choroid N. V., Glukhareva N.S. [Mycoplasma infection in respiratory disease in children]. Atmospherа. Puilmonologija i Аllergologija 2011; 3(42): 1–4. (In Russ.).

12. Pozdeev O. K. [Medical Microbiology. Textbook. Ed. by V. I. Pokrovsky]. Moscow: GEOTAR-Media, 2010; 426–30. (In Russ.).

13. Boyle E.M. Jr., Burdine J., Bolman R.M. Successful treatment of Mycoplasma mediastinitis after heart – lung transplantation. J. Heart. Lung. Transplant. 1993; 12(3): 508–20.

14. Camara B., Mouzin M., Ribes D., Esposito L., Guitard J. et al. Perihepatitis and perinephric abscess due to Mycoplasma hominis in a kidney transplant patients. Exp. Clin. Transplant. 2007; 5(2): 708–17.

15. Cordtz J., Jensen J.S. Disseminated Ureaplasma urealyticum infection in a hypogammaglobulinaemic renal transplant patient. Scand. J. Infect. Dis. 2006; 38(11–12): 1114–21.

16. Hopkins P.M., Winlaw D.S., Chhajed P.N., Harkness J.L., Horton M.D., Keogh A.M., Malouf M.A., Glanville A.R. Mycoplasma hominis infection in heart and lung transplantation. J. Heart. Lung. Transplant. 2002; 21(11): 1225–34.

17. Mitsani D., Nguyen M.H., Silveira F.P., Bermudez C., Toyoda Y., Pasculle A.W., Clancy C.J. Mycoplasma hominis pericarditis in a lung transplant recipient: review of the literature about an uncommon but important cardiothoracic pathogen. Transpl. Infect. Dis. 2010; 12(2): 146–96.

18. Lyon G.M., Alspaugh J.A., Meredith F.T., Harrell L.J., Tapson V., Davis R.D., Kanj S.S. Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. Chest 2010; 112 (5); 1428–60.

19. Tomaino J., Keegan T., Miloh T., Kerkar N., Mercer S., Birge M., Rocca J., Suchy F., Arnon R. Stevens–Jhnson syndrome after Mycoplasma pneumonia infection in pediatric post – liver transplant recipient: case report and review of the literature. Pediatr. Transplant. 2012; 16(3); 74–81.

20. Jacobs F., van de Stadt J., Gelin M., Nonhoff C., Gay F., Adler M., Thys J.P. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery 1992; 111(1): 98–100.


About the Autors


For correspondence: Nina I. Gabrielian, e-mail: labgso@mail.ru


Similar Articles


Бионика Медиа